Tirzepatide continues to be the most prescribed anti-diabetic (ADM) and anti-obesity (AOM) medication (sold as Mounjaro and Zepbound, respectively) and showed the largest increase in total prescribing from September to December 2025
Cuanto ms intenso sea el color de la carne roja, el contenido de este nutriente es mayor
Of the more than 20,000 people surveyed by the firms research arm, nearly 18 percent said they regained all the weight theyd lost but still, 56 percent said that they kept the weight off, and more than half of those respondents said they continued to lose weight in the year after stopping their injections
I was drinking water wildly, which isn't like me
GLP-1 Analogs When choosing a GLP-1 receptor agonist, options include long-acting vs short-acting agents, the need for reconstitution, patient preference, health insurance coverage & cost to the patient
What were the most striking differences